Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
Tuberculosis (TB) is a highly complex infectious disease caused by the intracellular pathogen Mycobacterium tuberculosis (Mtb). It is characterized by chronic granulomatous inflammation of the lung and systemic immune–neuroendocrine responses that have been associated with pathophysiology and diseas...
Main Authors: | Mario Zetter, Jorge Barrios-Payán, Dulce Mata-Espinosa, Brenda Marquina-Castillo, Andrés Quintanar-Stephano, Rogelio Hernández-Pando |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00351/full |
Similar Items
-
Vasopressin receptor antagonists and their role in clinical medicine
by: Girish Narayen, et al.
Published: (2012-01-01) -
Hemodynamic Management with Vasopressin for Cardiovascular Surgery
by: Hideyuki Kato, et al.
Published: (2024-12-01) -
Comparison of natural and artificial vasopressin deficiency: why the latter is lethal?
by: D. Zelena
Published: (2016-05-01) -
Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01) -
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment
by: Argelia Calvillo-Robledo, et al.
Published: (2023-03-01)